Cutler Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,500
| Closed | -$13K | – | 1458 |
|
|
2022
Q4 | $13K | Buy |
+1,500
| New | +$13K | ﹤0.01% | 1203 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1919 |
|
|
2022
Q2 | – | Sell |
-1,709
| Closed | -$21K | – | 1903 |
|
|
2022
Q1 | $21K | Buy |
+1,709
| New | +$21K | ﹤0.01% | 1345 |
|
|
2021
Q4 | – | Sell |
-2,500
| Closed | -$44K | – | 2065 |
|
|
2021
Q3 | $44K | Buy |
+2,500
| New | +$44K | ﹤0.01% | 1249 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2123 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2038 |
|
|
2019
Q2 | – | Sell |
-500
| Closed | -$1K | – | 1578 |
|
|
2019
Q1 | $1K | Sell |
500
-263
| -34% | -$526 | ﹤0.01% | 1407 |
|
|
2018
Q4 | $1K | Hold |
763
| – | – | ﹤0.01% | 1512 |
|
|
2018
Q3 | $2K | Hold |
763
| – | – | ﹤0.01% | 1469 |
|
|
2018
Q2 | $1K | Sell |
763
-1,450
| -66% | -$1.9K | ﹤0.01% | 1568 |
|
|
2018
Q1 | $6K | Sell |
2,213
-837
| -27% | -$2.27K | ﹤0.01% | 1504 |
|
|
2017
Q4 | $9K | Sell |
3,050
-14,489
| -83% | -$42.8K | ﹤0.01% | 1640 |
|
|
2017
Q3 | $72K | Buy |
17,539
+5,397
| +44% | +$22.2K | ﹤0.01% | 1124 |
|
|
2017
Q2 | $64K | Buy |
12,142
+6,795
| +127% | +$35.8K | ﹤0.01% | 1364 |
|
|
2017
Q1 | $30K | Sell |
5,347
-4,403
| -45% | -$24.7K | ﹤0.01% | 1705 |
|
|
2016
Q4 | $38K | Buy |
9,750
+5,933
| +155% | +$23.1K | ﹤0.01% | 1631 |
|
|
2016
Q3 | $13K | Sell |
3,817
-5,322
| -58% | -$18.1K | ﹤0.01% | 2006 |
|
|
2016
Q2 | $55K | Buy |
9,139
+1,900
| +26% | +$11.4K | ﹤0.01% | 1326 |
|
|
2016
Q1 | $35K | Buy |
7,239
+6,639
| +1,107% | +$32.1K | ﹤0.01% | 1466 |
|
|
2015
Q4 | $3K | Buy |
+600
| New | +$3K | ﹤0.01% | 2610 |
|